CorVent Medical

Executive Summary

CorVent Medical is a U.S.-based medical device company founded in 2020, headquartered in Santa Clara, California. The company develops and commercializes simple, safe, and smart respiratory ventilation solutions, primarily the RESPOND® ventilator and CorVision™ platform. These products are designed for use in hospitals, long-term care facilities, and government stockpiles, with a focus on reducing complexity and cost in critical care ventilation. By addressing the limitations of traditional ventilators, CorVent aims to improve patient outcomes and operational efficiency in respiratory care. Respiratory ventilation remains a critical area of healthcare, especially in the wake of global pandemic preparedness and aging populations. CorVent's differentiated approach emphasizes ease of use, reliability, and advanced monitoring via the CorVision platform, positioning it to capture market share in both acute and non-acute settings. With a strong emphasis on meeting regulatory standards and addressing unmet needs, CorVent Medical is poised for growth as it seeks to expand its commercial footprint and secure strategic partnerships. The company's technology has the potential to become a standard in ventilator stockpiles and long-term care, providing a scalable solution to a persistent healthcare challenge.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for New Ventilator Indication60% success
• Q2 2026Major Government Stockpile Contract (e.g., U.S. DHHS)70% success
• Q4 2026Series B Funding Round to Support Commercial Expansion65% success